During the past decade, Health Step Finland Oy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Health Step Finland Oy" are "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetic Kidney Disease" (1 trials), "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Health Step Finland Oy" in a lesser frequency.

Most popular intervention types in "Health Step Finland Oy" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY1817080" (1 trials). Other intervention names were less common.

The vast majority of trials in "Health Step Finland Oy" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Health Step Finland Oy". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Health Step Finland Oy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Health Step Finland Oy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".